Pulmonary metastasectomy: What is the practice and where is the evidence for effectiveness?

Thorax

Volumn 69, Issue 10, 2014, Pages 946-949

  Treasure, Tom ^a   Miloševíc, Mišel ^b   Fiorentino, Francesca ^c   Macbeth, Fergus ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; HEALTH; HUMAN; LUNG TUMOR; MELANOMA; METASTASIS; METASTASIS RESECTION; METHODOLOGY; MORTALITY; PATHOLOGY; REVIEW; SARCOMA; SKIN TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MELANOMA; METASTASECTOMY; SARCOMA; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84892456883     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204528     Document Type: Review

References (41)

1. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
2. Pastorino U. The development of an international registry. J Thorac Oncol 2010;5(6 Suppl 2):S196-7.
3. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10.
4. Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med 2012;105:242-6.
5. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378-82.
6. Sturgeon CM, Lai LC, Duffy MJ. Serum tumour markers: how to order and interpret them. BMJ 2009;339:b3527.
7. Pfannschmidt J, Zabeck H, Muley T, et al. Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: experience in 52 patients. Thorac Cardiovasc Surg 2006;54:484-8.
8. Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 2013;20:572-9.
9. Treasure T. Carcinoembryonic antigen: its place in decision making for pulmonary metastasectomy in colorectal cancer. J Thorac Oncol 2010;5(6 Suppl 2):S179-81.
10. Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer. JAMA 1994;272:31.
11. Pfannschmidt J, Hoffmann H, Dienemann H. Thoracic metastasectomy for nonseminomatous germ cell tumors. J Thorac Oncol 2010;5(6 Suppl 2):S182-6.
12. Besse B, Grunenwald D, Flechon A, et al. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. J Thorac Cardiovasc Surg 2009;137:448-52.
13. Treasure T, Fiorentino F, Scarci M, et al. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open 2012;2:5. doi:10.1136 bmjopen-2012-001736.
14. Kager L, Zoubek A, Potschger U, et al . Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011-18.
15. Gelderblom H, Jinks RC, Sydes M, et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 2011;47:895-902.
16. National Institute for Health and Care Excellence (NICE). Guidance on Cancer Services. Improving Outcomes for People with Sarcoma. The Manual . The National Institute for Health and Care Excellence (NICE), 2006. http://www.nice.org.uk/nicemedia/live/10903/28934/28934.pdf
17. Treasure T, Utley M. Surgical removal of asymptomatic pulmonary metastases: time for better evidence. BMJ 2013;346:21-3.
18. Van Raemdonck D, Friedel G. The European society of thoracic surgeons lung metastasectomy project. J Thorac Oncol 2010;5(6 Suppl 2):S127-9.
19. Oliaro A, Filosso PL, Bruna MC, et al. Pulmonary metastasectomy for melanoma. J Thorac Oncol 2010;5(6 Suppl 2):S187-91.
20. Tafra L, Dale PS, Wanek LA, et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 1995;110:119-28.
21. Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007;133:104-10.
22. Treasure W. Diagnosis and Risk Management in Primary Care: words that count, numbers that speak. London: Radcliffe Publishing, 2011.
23. Fiorentino F, Hunt I, Teoh K, et al. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med 2010;103:60-6.
24. Ollila DW, Stern SL, Morton DL. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol 1998;69:206-11.
25. Yang JC, Abad J, Sherry R. Treatment of oligometastases after successful immunotherapy. Semin Radiat Oncol 2006;16:131-5.
26. Fiorentino F, Vasilakis C, Treasure T. Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis. Br J Cancer 2011;104:1085-97.
27. Embun R, Fiorentino F, Treasure T, et al. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open 2013;3:e002787.
28. Treasure T, Utley M. Statistics for the rest of us: ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133:1414-18.
29. Simms L, Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know-prognostic and predictive factors. J Thorac Oncol 2013;8:808-13.
30. Garcia-Yuste M, Cassivi S, Paleru C. Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis. J Thorac Oncol 2010;5(6 Suppl 2):S166-9.
31. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007;84:324-38.
32. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol 2010;5(6 Suppl 2):S172-8.
33. Utley M, Treasure T, Linklater K, et al. Better out than in? The resection of pulmonary metastases from colorectal tumours. In: Xie X, Lorca F, Marcon E. eds. Operations Research for Health Care Engineering: Proceedings of the 33rd International Conference on Operational Research Applied to Health Services. Saint-Etienne: Publications de l'Universitaire de Saint-Etienne, 2008:493-500.
34. Aberg T, Malmberg KA, Nilsson B, et al. The effect of metastasectomy: fact or fiction? Ann Thorac Surg 1980;30:378-84.
35. Utley M, Treasure T. Interpreting data from surgical follow-up studies: the role of modeling. J Thorac Oncol 2010;5(6 Suppl 2):S200-2.
36. Levesque LE, Hanley JA, Kezouh A, et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010;340:b5087.
37. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16:241-9.
38. Jaklitsch MT, Mery CM, Lukanich JM, et al. Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. J Thorac Cardiovasc Surg 2001;121:657-67.
39. Burt BM, Ocejo S, Mery CM, et al. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg 2011;92:1202-7.
40. Bradford Hill A. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
41. Glasziou P, Chalmers I, Rawlins M, et al. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349-51.